Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Times Interest Earned (2016 - 2021)

GT Biopharma (GTBP) has disclosed Times Interest Earned for 12 consecutive years, with -$826.27 as the latest value for Q4 2021.

  • On a quarterly basis, Times Interest Earned fell 54047.5% to -$826.27 in Q4 2021 year-over-year; TTM through Dec 2021 was -$80.1, a 336.86% decrease, with the full-year FY2025 number at -$97.81, changed N/A from a year prior.
  • Times Interest Earned was -$826.27 for Q4 2021 at GT Biopharma, down from -$41.67 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $1.68 in Q1 2020 to a low of -$826.27 in Q4 2021.
  • A 5-year average of -$78.01 and a median of -$3.6 in 2019 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: soared 118.77% in 2020, then crashed 54047.5% in 2021.
  • GT Biopharma's Times Interest Earned stood at -$43.64 in 2017, then tumbled by 378.86% to -$208.96 in 2018, then surged by 65.24% to -$72.64 in 2019, then soared by 97.9% to -$1.53 in 2020, then crashed by 54047.5% to -$826.27 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Times Interest Earned are -$826.27 (Q4 2021), -$41.67 (Q1 2021), and -$1.53 (Q4 2020).